Nanomedicines may offer clinicians a way to deliver precise, targeted therapy directly to tumors without damaging surrounding tissue. Yet, progress in the development of new drugs that treat cancer at the nanoparticle level has been frustratingly slow. Good results in animal models haven’t necessarily translated to clinical success in humans, in part because of low delivery efficiency of nanoparticles to tumors.
Now, with the support of a new $1.3 million grant from the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health, researchers led by Zhoumeng Lin, B.Med., Ph.D., DABT, CPH, are building a tool that can offer drug researchers insight into how well a new nanoparticle-based cancer therapy will work, even before a drug enters animal testing.
This project will provide a tangible tool to improve the design of nanoparticles to accelerate clinical translation of cancer nanomedicines from animals to humans in order to benefit cancer patients.
Zhoumeng Lin, Associate Professor, Department of Environmental and Global Health, College of Public Health and Health Professions
Another anticipated benefit is the reduction or elimination of animal experimentation for new nanomedicines that are determined to have low delivery efficiency, Lin added.
Lin joined the university this summer from Kansas State University. He is the first faculty member in PHHP hired under UF’s artificial intelligence initiative, which seeks to make the university a national leader in AI. Lin’s expertise is in the development and application of computational technologies to address research questions related to nanomedicine, animal-derived food safety assessment, and environmental chemical risk assessment.
To build their predictive model of nanoparticle cancer therapies, researchers will use an AI technology known as artificial neural network and train it with hundreds of datasets from physiologically-based pharmacokinetic (PBPK) computer models. PBPK models describe the absorption, distribution, metabolism and excretion of a drug in the body using mathematical equations, and they can be used to predict the concentration of a drug following different therapies.
In this project, we will integrate PBPK modeling with AI approaches to build an AI-assisted smart model that can predict delivery efficiency of nanoparticles to tumors,” Lin said. “This approach is new in the fields of nanomedicine, pharmacology and toxicology.
Zhoumeng Lin, Associate Professor, Department of Environmental and Global Health, College of Public Health and Health Professions
Next, Lin’s co-investigator, Santosh Aryal, Ph.D., an associate professor in the department of pharmaceutical sciences and health outcomes at the University of Texas at Tyler, will conduct pharmacokinetic lab experiments using nanoparticles. The data from these experiments will be used to validate and/or optimize the new AI-PBPK model.
“We are excited about this collaboration and hope this will further open up novel avenues in cancer nanomedicine development,” Aryal said.
For the project’s final outcome, the team will convert the smart model into a publicly available web-based interface for use by nanomedicine researchers.
“This project addresses a crucial problem of low delivery efficiency of cancer nanomedicines, which has been a critical barrier to progress over the last 20 years,” Lin said. “This will greatly improve our fundamental understanding of the key factors of nanoparticle tumor delivery.”
News
“Great Unified Microscope” Reveals Hidden Micro and Nano Worlds Inside Living Cells
University of Tokyo researchers have created a powerful new microscope that captures both forward- and back-scattered light at once, letting scientists see everything from large cell structures to tiny nanoscale particles in a single shot. Researchers [...]
Breakthrough Alzheimer’s Drug Has a Hidden Problem
Researchers in Japan found that although the Alzheimer’s drug lecanemab successfully removes amyloid plaques from the brain, it does not restore the brain’s waste-clearing system within the first few months of treatment. The study suggests that [...]
Concerning New Research Reveals Colon Cancer Is Skyrocketing in Adults Under 50
Colorectal cancer is striking younger adults at alarming rates, driven by lifestyle and genetic factors. Colorectal cancer (CRC) develops when abnormal cells grow uncontrollably in the colon or rectum, forming tumors that can eventually [...]
Scientists Discover a Natural, Non-Addictive Way To Block Pain That Could Replace Opioids
Scientists have discovered that the body can naturally dull pain through its own localized “benzodiazepine-like” peptides. A groundbreaking study led by a University of Leeds scientist has unveiled new insights into how the body manages pain, [...]
GLP-1 Drugs Like Ozempic Work, but New Research Reveals a Major Catch
Three new Cochrane reviews find evidence that GLP-1 drugs lead to clinically meaningful weight loss, though industry-funded studies raise concerns. Three new reviews from Cochrane have found that GLP-1 medications can lead to significant [...]
How a Palm-Sized Laser Could Change Medicine and Manufacturing
Researchers have developed an innovative and versatile system designed for a new generation of short-pulse lasers. Lasers that produce extremely short bursts of light are known for their remarkable precision, making them indispensable tools [...]
New nanoparticles stimulate the immune system to attack ovarian tumors
Cancer immunotherapy, which uses drugs that stimulate the body’s immune cells to attack tumors, is a promising approach to treating many types of cancer. However, it doesn’t work well for some tumors, including ovarian [...]
New Drug Kills Cancer 20,000x More Effectively With No Detectable Side Effects
By restructuring a common chemotherapy drug, scientists increased its potency by 20,000 times. In a significant step forward for cancer therapy, researchers at Northwestern University have redesigned the molecular structure of a well-known chemotherapy drug, greatly [...]
Lipid nanoparticles discovered that can deliver mRNA directly into heart muscle cells
Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have stalled, largely due to the difficulty of delivering treatments at the cellular level. Now, a UC Berkeley-led [...]
The basic mechanisms of visual attention emerged over 500 million years ago, study suggests
The brain does not need its sophisticated cortex to interpret the visual world. A new study published in PLOS Biology demonstrates that a much older structure, the superior colliculus, contains the necessary circuitry to perform the [...]
AI Is Overheating. This New Technology Could Be the Fix
Engineers have developed a passive evaporative cooling membrane that dramatically improves heat removal for electronics and data centers Engineers at the University of California San Diego have created an innovative cooling system designed to greatly enhance [...]
New nanomedicine wipes out leukemia in animal study
In a promising advance for cancer treatment, Northwestern University scientists have re-engineered the molecular structure of a common chemotherapy drug, making it dramatically more soluble and effective and less toxic. In the new study, [...]
Mystery Solved: Scientists Find Cause for Unexplained, Deadly Diseases
A study reveals that a protein called RPA is essential for maintaining chromosome stability by stimulating telomerase. New findings from the University of Wisconsin-Madison suggest that problems with a key protein that helps preserve chromosome stability [...]
Nanotech Blocks Infection and Speed Up Chronic Wound Recovery
A new nanotech-based formulation using quercetin and omega-3 fatty acids shows promise in halting bacterial biofilms and boosting skin cell repair. Scientists have developed a nanotechnology-based treatment to fight bacterial biofilms in wound infections. The [...]
Researchers propose five key questions for effective adoption of AI in clinical practice
While Artificial Intelligence (AI) can be a powerful tool that physicians can use to help diagnose their patients and has great potential to improve accuracy, efficiency and patient safety, it has its drawbacks. It [...]
Advancements and clinical translation of intelligent nanodrugs for breast cancer treatment
A comprehensive review in "Biofunct. Mater." meticulously details the most recent advancements and clinical translation of intelligent nanodrugs for breast cancer treatment. This paper presents an exhaustive overview of subtype-specific nanostrategies, the clinical benefits [...]
